Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Compass Therapeutics, Inc. (CMPX) had Operating Cash Flow per Share of $-0.18 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-19.88M |
|
-- |
|
-- |
|
$21.07M |
|
$-21.07M |
|
$1.19M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-19.88M |
|
$-21.07M |
|
$-20.83M |
|
138.28M |
|
138.28M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$106.19M |
|
$0.13M |
|
$10.50M |
|
$116.70M |
|
$13.86M |
|
-- |
|
$9.63M |
|
$23.49M |
|
$93.21M |
|
$93.21M |
|
$93.21M |
|
138.28M |
|
| Cash Flow Statement Financials | |
$-25.04M |
|
$5.23M |
|
$-0.81M |
|
$44.05M |
|
$23.42M |
|
$-20.63M |
|
$5.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.33% |
|
-21.33% |
|
-17.04% |
|
-21.33% |
|
$0.67 |
|
$-0.18 |
|
|
Operating Cash Flow per Share |
$-0.18 |